跳至主要内容
临床试验/EUCTR2011-002677-30-DK
EUCTR2011-002677-30-DK进行中(未招募)1 期

Preclinical phase 0 micro dose study to evaluate the effekt of R-CHOP chemotherapy on cellular gene-expression.- Establisment of a preclinical model for in vivo evaluation of molecular biological efects. - R-CHOP phase 0

Professor Hans Erik Johnsen, MD, DMSc, Department of Haematology, Aalborg Hospital0 个研究点目标入组 42 人开始时间: 2011年8月9日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Any patient who have
  • 1) planned treatment with R-CHOP or different R-chemotherapy for a haematologic disease in accordance with current guidelines at Aalborg Hospital.
  • 2) age above 18 yrs.
  • 3) ability to undestand and will to sign the informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 42
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 42

排除标准

  • Any patient who
  • 1) due to adverse reactions have their regular treatment cancelled.

研究者

发起方
Professor Hans Erik Johnsen, MD, DMSc, Department of Haematology, Aalborg Hospital

相似试验